Stock listing
NASDAQ:VTYX Ventyx Biosciences Inc Stock
Follow Ventyx Biosciences Inc into a list and get an email when it puts out news.
Last close · NASDAQ:VTYX
$14.00 USD
Close on Mar 3, 2026 · No longer trades
- Lowest – highest close
- $0.836 – $46.65 USDSince Oct 21, 2021 · lowest Apr 7, 2025 · highest Mar 3, 2023
Delisted NASDAQ:VTYX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:VTYX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Ventyx Biosciences Inc on 6ix
- Calls
- 6 calls with a replay · 6 with a transcript · latest May 9, 2024
- Decks
- 9 decks · latest Oct 22, 2025
Events
| Call | When | Status |
|---|---|---|
| Ventyx Biosciences (VTYX) Q1 2024 Earnings Call | Thu, May 09, 2024 · 4:30 PM ET | Replay |
| Ventyx Biosciences (VTYX) Q2 2023 Earnings Call | Thu, Aug 10, 2023 · 4:30 PM ET | Replay |
| Ventyx Biosciences (VTYX) Q1 2023 Earnings Call | Thu, May 11, 2023 · 4:30 PM ET | Replay |
| Ventyx Biosciences (VTYX) Q4 2022 Earnings Call | Thu, Mar 23, 2023 · 4:30 PM ET | Replay |
| Ventyx Biosciences (VTYX) Q2 2022 Earnings Call | Mon, Aug 15, 2022 · 4:30 PM ET | Replay |
| Ventyx Biosciences (VTYX) Q1 2022 Earnings Call | Thu, May 12, 2022 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (October 2025) | Technical | 30 slides | Oct 22, 2025 |
| Investor Presentation (January 2025) | Investor deck | 40 slides | Jan 14, 2025 |
| Technical Presentation (November 2023) | Technical | 14 slides | Nov 6, 2023 |
| Technical Presentation (October 2023) | Technical | 20 slides | Oct 10, 2023 |
| Investor Day (January 2023) | Investor day | 72 slides | Jan 26, 2023 |
| Investor Presentation (November 2022) | Investor deck | 44 slides | Nov 30, 2022 |
| Investor Presentation (June 2022) | Investor deck | 37 slides | Jun 29, 2022 |
| Investor Presentation (March 2022) | Investor deck | 36 slides | Mar 15, 2022 |
| Investor Presentation (November 2021) | Investor deck | 33 slides | Nov 30, 2021 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Onaiza Cadoret-Manier Other companies: Ardelyx, Inc. (Director · Since at least Mar 12, 2020); Ionis Pharmaceuticals, Inc. (EVP,Chf GL Pdt Str & Oper Ofc · Jan 9, 2020 – Feb 2, 2024 · Past) | Director · Since at least Jan 11, 2023 |
| William Richard White Other companies: Disc Medicine, Inc. (Director · Since at least Jun 11, 2025); Akero Therapeutics Inc (Chief Financial Officer · Since at least Jun 10, 2025) | Director · Since at least Jun 5, 2025 |
| Mark S Forman Other companies: Passage Bio, Inc. (CHIEF MEDICAL OFFICER · Mar 30, 2022 – Mar 15, 2024 · Past) | Chief Medical Officer · Since at least Aug 12, 2024 |
| Somu Subramaniam Other companies: icad inc (Director · Dec 30, 2010 – Sep 28, 2018 · Past) | Director · Since at least Oct 20, 2021 |
| Allison Hulme | Director · Since at least Jan 11, 2023 |
| Christopher W Krueger | CHIEF BUSINESS OFFICER · Oct 20, 2021 – Apr 2, 2024 · Past |
| Martin Auster | CHIEF FINANCIAL OFFICER · Oct 20, 2021 – Apr 2, 2024 · Past |
| Raju Mohan | CEO AND PRESIDENT, Director · Since at least Oct 20, 2021 |
| Roy Gonzales | Senior VP, Finance · Since at least Aug 30, 2024 |
Log in to ask 6ix AI your own questions about Ventyx Biosciences Inc.